Study title: Theophylline retard capsules, 250 mg. Efficacy, tolerability and steady-state serum concentrationTheophylline retard capsules, 250 mg. Efficacy, tolerability and steady-state serum concentration
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: Respiratory Tract Diseases [C08] | |||||
Brands: Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: AMINOPHYLLINE + THEOPHYLLINE | |||||
ATC code: R03DA04 | |||||
Document link: Study report 84-83 Theophylline - synopsis German.pdf | |||||
Document date: 2011-09-27 | |||||
Study number: 84/83 | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |